# Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

> **NCT05286294** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma Stage IV
- Head and Neck Squamous Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- MSI-High
- Clear Cell Renal Cell Carcinoma
- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplant (FMT)

## Key facts

- **NCT ID:** NCT05286294
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-28
- **Primary completion:** 2034-03-31
- **Final completion:** 2034-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286294, "Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05286294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*